Fibromyalgia: Time to Consider a New Taxonomy?

REFERENCES

• Goldenberg D L. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. J Rheumatol Suppl 1989; 19: 91–93
   PubMedGoogle Scholar
• Berg P A, Klein R. Fibromyalgie-Syndrom; eine neuroendokrinologische Autoimmunerkrankung?. Dtsch Med Wochenschr 1994; 119(12)429–435
   PubMedGoogle Scholar
• Wolfe F, Ross K, Anderson J, Russell I J, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28
   PubMed Web of Science ®Google Scholar
• Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 1997; 157(21)2497–2500
   PubMed Web of Science ®Google Scholar
• Clauw D J, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res 1997; 31(1)125–131
   PubMed Web of Science ®Google Scholar
• Ackenheil M. Genetics and pathophysiology of affective disorders: relationship to fibromyalgia. Z Rheumatol 1998; 57(suppl. 2)5–7
   PubMedGoogle Scholar
• Crofford L J. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol 1998; 57(suppl. 2)67–71
   PubMed Web of Science ®Google Scholar
• Krause K-H, Krause J, Magyarosy I, Ernst E, Pongratz D. Fibromyalgia syndrome and attention deficit hyperactivity disorder: is there a comorbidity and are there consequences for the therapy of fibromyalgia syndrome?. J Musculoske Pain 1998; 6(4)111–116
   Web of Science ®Google Scholar
• Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 1998; 57(suppl. 2)94–96
   PubMedGoogle Scholar
• Adler G K, Kinsley B T, Hurwitz S, Mossey C J, Goldenberg D L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106(5)534–543
   PubMed Web of Science ®Google Scholar
• Buskila D, Odes L R, Neumann L, Odes H S. Fibromyalgia in inflammatory bowel disease. J Rheumatol 1999; 26(5)1167–1171
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbraun A S, Masi A T, McGain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33(2)160–172
   PubMed Web of Science ®Google Scholar
• Henriksson K G, Bengtsson A, Larsson J, Lindstrom F, Thornell L E. Muscle biopsy findings of possible diagnostic importance in primary fibromyalgia (fibrositis, myofascial syndrome). Lancet 1982; 2(8312), 1395
   PubMedGoogle Scholar
• Bartels E M, Danneskiold-Samsøe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet 1986; 1(8484)755–757
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Henriksson K G, Larsson J. Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings. Scand J Rheumatol 1986; 15(1)1–6
   PubMed Web of Science ®Google Scholar
• Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986; 15(2)165–173
   PubMed Web of Science ®Google Scholar
• Larsson S E, Bengtsson A, Bodegård L, Henriksson K G, Larsson J. Muscle changes in work-related chronic myalgia. Acta Orthop Scand 1988; 59(5)552–556
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Henriksson K G. The muscle in fibromyalgia-a review of Swedish studies. J Rheumatol 1989; 19(suppl)144–149
   Google Scholar
• Yunus M B, Kalyan-Raman U P, Masi A T, Aldag J C. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989; 16(1)97–101
   PubMed Web of Science ®Google Scholar
• Jacobsen S, Bartels E M, Danneskiold-Samsøe B. Single cell morphology of muscle in patients with chronic muscle pain. Scand J Rheumatol 1991; 20(5)336–343
   PubMed Web of Science ®Google Scholar
• Schrøder H D, Drewes A M, Andreasen A. Muscle biopsy in fibromyalgia. J Musculoske Pain 1993; 1(3/4)165–169
   Google Scholar
• Jubrias S A, Bennett R M, Klug G A. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum 1994; 37(6)801–807
   PubMedGoogle Scholar
• Nørregaard J, Harreby M, Amris K, Bangsbo J, Bartels E M, Danneskiold-Samsøe B. Single cell morphology and high-energy phosphate levels in quadriceps muscles from patients with fibromyalgia. J Musculoske Pain 1994; 2(2)45–51
   Google Scholar
• Sprott H, Müller A, Heine H. Collagen crosslinks in fibromyalgia. Arthritis Rheum 1997; 40(8)1450–1454
   PubMed Web of Science ®Google Scholar
• Mengshoel A M. Fibromyalgia and responses to exercise. J Manual & Manipulative Therapy 1998; 6(3)144–150
   Google Scholar
• Pongratz D E, Späth M. Morphologic aspects of fibromyalgia. Z Rheumatol 1998; 57(suppl. 2)47–51
   PubMedGoogle Scholar
• Sietsema K E, Cooper D M, Caro X, Leibling M R, Louie J S. Oxygen uptake during exercise in patients with primary fibromyalgia syndrome. J Rheumatol 1993; 20(5)860–865
   PubMed Web of Science ®Google Scholar
• Nørregaard J, Bulow P M, Mehlsen J, Danneskiold-Samsøe B. Biochemical changes in relation to a maximal exercise test in patients with fibromyalgia. Clin Physiol 1994; 14(2)159–167
   PubMedGoogle Scholar
• Simms R W, Roy S H, Hrovat M, Anderson J J, Skrinar G, LePoole S R, Zerbini C A, de Luca C, Jolesz F. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 1994; 37(6)794–800
   PubMed Web of Science ®Google Scholar
• Simms R W. Muscle studies in fibromyalgia. J Musculoske Pain 1994; 2(3)117–123
   Google Scholar
• Mengshoel A M, Saugen E, Forre O, Vollestad N K. Muscle fatigue in early fibromyalgia. J Rheumatol 1995; 22(1)143–150
   PubMedGoogle Scholar
• Vestergaard-Poulsen P, Thomsen C, ørregaard J, Bulow P, Sinkjaer T, Henriksen O. 31P NMR spectroscopy and electromyography during exercise and recovery in patients with fibromyalgia. J Rheumatol 1995; 22(8)1544–1551
   PubMedGoogle Scholar
• Simms R W. Is there muscle pathology in fibromyalgia syndrome?. Rheum Dis Clin North Am 1996; 22(2)245–266
   PubMedGoogle Scholar
• Cohen M L, Sheather-Reid R B, Arroyo J F, Champion G D. Evidence for abnormal nociception in fibromyalgia and repetitive strain injury. J Musculoke Pain 1995; 3(2)49–57
   Google Scholar
• McDermid A J, Rollman G B, McCain G A. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 1996; 66(2–3)133–144
   PubMedGoogle Scholar
• Bendtsen L, Nørregaard J, Jensen R, Olesen J. Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 1997; 40(1)98–102
   PubMed Web of Science ®Google Scholar
• Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 1998; 57(suppl. 2)19–22
   PubMedGoogle Scholar
• Vecchiet L, Pizzigallo E, Iezzi S, Affaitati G, Vecchiet J, Giamberardino M A. Differentiation of sensitivity in different tissues and its clinical significance. J Musculoske Pain 1998; 6(1)33–45
   Web of Science ®Google Scholar
• Kosek E, Ekholm J, Hansson P. Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain 1995; 63(3)335–339
   PubMed Web of Science ®Google Scholar
• Kosek E, Ekholm J, Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 1996; 64(3)415–423
   PubMed Web of Science ®Google Scholar
• Gibson S J, Littlejohn G O, Gorman M M, Helme R D, Granges G. Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994; 58(2)185–193
   PubMed Web of Science ®Google Scholar
• Nørregaard J, Bendtsen L, Lykkegaard J, Jensen R. Pressure and heat pain thresholds and tolerances in patients with fibromyalgia. J Musculoske Pain 1996; 5(2)43–53
   Google Scholar
• Wolfe F. Fibromyalgia and problems in classification of musculoskeletal disorders. Progress in fibromyalgia and myofascial pain. Pain research and clinical management, H Værøy, H Merskey. Elsevier, Amsterdam 1993; 217–235
   Google Scholar
• Graven-Nielsen T, Sörensen J, Henriksson K G, Bengtsson M, Arendt-Nielsen L. Central hyperexcitability in fibromyalgia. J Musculoske Pain 1999; 7(1/2)261–271
   Google Scholar
• Værøy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988; 32(1)21–26
   PubMed Web of Science ®Google Scholar
• Russell I J, Orr M D, Littman B, Vipraio G A, Alboukrek D, Michalek J E, Lopez Y, MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37(11)1593–601
   PubMed Web of Science ®Google Scholar
• Welin M, Bragee B, Nyberg F, Kristiansson M. Elevated substance P levels are contrasted by a decrease in met-enkephalin-arg-phe levels in csf from fibromyalgia patients. J Musculoske Pain 1995; 3(3), 4(abstract)
   Google Scholar
• Russell I J. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoske Pain 1999; 7(1/2)183–191
   Google Scholar
• Hrycaj P, Stratz T, Muller W. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1993; 20(11)1986–1988
   PubMedGoogle Scholar
• Russell I J, Vipraio G A, Acworth I. Abnormalities in the central nervous system (CNS) metabolism of tryptophan (TRY) to 3-hydroxy kynurenine (OHKY) in fibromyalgia syndrome (FS). Arthritis Rheum 1993; 36(9), S222(abstract)
   Google Scholar
• Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, Müller W. Die Serotoninkonzentration im Serum bei Patienten mit generalisierter Tendomyopathie (Fibromyalgie) und chronischer Polyarthritis. Med Klin 1993; 88(8)458–462
   Google Scholar
• Russell I J. Biochemical abnormalities in fibromyalgia syndrome. J Musculoske Pain 1994; 2(3)101–115
   Google Scholar
• Russell I J. Substance P and fibromyalgia. J Musculoske Pain 1998; 6(3)29–35
   Web of Science ®Google Scholar
• Neeck G, Riedel W. Hormonal pertubations in fibromyalgia syndrome. Ann N Y Acad Sci 1999; 876: 325–338
   PubMed Web of Science ®Google Scholar
• Bonica J J. Definitions and taxonomy of pain. The management of pain, J J Bonica, J D Loesser, C R Chapman, W E Fordyce. Lea & Febiger, Philadelphia 1990; 18–27
   Google Scholar
• Russell I J. Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoske Pain 1996; 4(1/2)61–92
   Google Scholar
• Stanton-Hicks M, Jänig W, Hassenbusch S, Haddox J D, Boas R, Wilson P. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995; 63(1)127–133
   PubMed Web of Science ®Google Scholar